News & Videos - ALLERGAN PLC - English

Allergan Aesthetics Announces the Return of CoolMonth with CoolSculpting® PR Newswire IRVINE, Calif., April 3, 2024 Offering $200 Off the First CoolSculpting ® Treatment IRVINE, Calif. , April 3, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) is announcing its second annual CoolMonth celebration featuring CoolSculpting® Elite. From April 1 through April 30, 2024 , consumers can access CoolSavings promotions to help accelerate their body contouring journey. Leveraging...

Allergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom Project PR Newswire IRVINE, Calif., Oct. 19, 2023 Ongoing Support for Breast Cancer Patients Through Initiatives Focused on Education and Elevating Patient Voices IRVINE, Calif. , Oct. 19, 2023 /PRNewswire/ -- Yesterday, on Breast Reconstruction Awareness Day (National BRA Day), Allergan Aesthetics, an AbbVie company (NYSE: ABBV), launched Reblossom , a coffee table book...

Allergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field PR Newswire IRVINE, Calif., Oct. 3, 2023 -- Girls Inc. alumnae in New York , San Antonio and Central Alabama will participate in a virtual panel titled 'Equipping the New Generation of STEM Leaders' with leading women physicians sharing their career journeys including growth moments and challenges -- A social media campaign shares authentic stories and aspirations of girls...

Allergan Aesthetics* to showcase 360° approach to clinical practice, aesthetic products, and patients with expert-led symposia at AMWC 2023 PR Newswire IRVINE, Calif., March 29, 2023 -- 'Discover Your 360°' immersive experience to feature across Allergan Aesthetics events, supporting customers with all aspects of their Practice, Product and Patient needs -- -- Two expert-led Allergan Medical Institute (AMI) symposia to discuss a 360° approach to consultation and treatment, featuring live...

Allergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023 PR Newswire IRVINE, Calif., Jan. 25, 2023 IRVINE, Calif. , Jan. 25, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today unveiled at the 24 th International Master Course on Aging Science (IMCAS) World Congress its immersive experience 'Discover your 360 °' . This is a customer centric approach, which...

GLO PHARMA APPOINTS CURRENT EXECUTIVE CHAIRMAN OF THE BEAUTY HEALTH COMPANY AND FORMER ALLERGAN PLC CEO BRENT SAUNDERS TO ITS BOARD OF DIRECTORS PR Newswire NEW YORK, Aug. 24, 2022 NEW YORK , Aug. 24, 2022 /PRNewswire/ -- GLO Pharma, the parent company of breakthrough subtopical skincare brand Ourself, today announces the appointment of Brent Saunders to its Board of Directors. Mr. Saunders, who currently serves as Executive Chairman of The Beauty Health Company, will join the board effective...

Resorts World Las Vegas and Concerts West / AEG Presents have entered into a first-of-its-kind agreement with Allergan Aesthetics, an AbbVie company (NYSE: ABBV), to become the preferred aesthetics and rewards partner for Resorts World Las Vegas. As part of the multiyear agreement brokered by AEG Global Partnerships and Resorts World Las Vegas, Allergan Aesthetics will have exclusive branding rights to the property’s 66 th floor lounge, now known as Allē Lounge on 66, and Resorts World...

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign BRAND UNVEILS 'SEE YOURSELF' DOCUMENTARY STYLE CONTENT SERIES HIGHLIGHTING THE PEOPLE WHO GET TREATED WITH BOTOX® COSMETIC AND THEIR REASON WHY PR Newswire IRVINE, Calif., June 8, 2021 IRVINE, Calif. , June 8, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with...

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio -- Acquisition adds Rapid Acoustic Pulse technology platform for improvement in appearance of cellulite in the buttocks and thighs -- PR Newswire IRVINE, Calif. and HOUSTON, May 10, 2021 IRVINE, Calif. and HOUSTON , May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and...

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio -- Acquisition adds Rapid Acoustic Pulse technology platform for improvement in appearance of cellulite in the buttocks and thighs -- PR Newswire IRVINE, Calif. and HOUSTON, May 10, 2021 IRVINE, Calif. and HOUSTON , May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and...

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite NEW TECHNOLOGY ALLOWS FOR THE TREATMENT OF TWO AREAS OF FAT AT ONCE AND NEW ELITE APPLICATORS DESIGNED FOR IMPROVED FIT AND COMFORT PR Newswire IRVINE, Calif., Jan. 26, 2021 IRVINE, Calif. , Jan. 26, 2021 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of CoolSculpting ® Elite, its next generation fat reduction system with applicators designed to...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allergan plc (“Allergan” or “the Company”) (NYSE: AGN ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Allergan failed to inform investors that its CE Mark for textured breast implants and tissue expanders was...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allergan plc (“Allergan” or “the Company”) (NYSE: AGN ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Allergan failed to inform investors that its CE Mark for textured breast implants and tissue expanders was...

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Allergan plc Investors to Contact Firm Before Important October 29 Deadline in Class Action Seeking Recovery of Investor Losses; Encourages Investors with Losses in Excess of $500K to Contact the Firm - AGN PR Newswire NEW YORK, Oct. 15, 2020 NEW YORK , Oct. 15, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc (NYSE: AGN) between January 30, 2017 and December 19, 2018 ,...

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allergan plc ("Allergan" or the "Company") (NYSE: AGN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Allergan shares between May 9, 2017, and December 19, 2018, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff please visit our firm’s site: www.bgandg.com/agn1 . This class action seeks to...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc (NYSE: AGN) between January 30, 2017 and December 19, 2018, inclusive (the “Class Period”), of the important October 29, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Allergan investors under the federal securities laws. To join the Allergan class action, go to http://www.rosenlegal.com/cases-register-1967.html or call Phillip Kim,...

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc (“Allergan” or “the Company”) (NYSE: AGN ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 9, 2017 and December 19, 2018, inclusive (the ''Class Period''), are encouraged to...

AGN Investor Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan plc and Lead Plaintiff Deadline - October 29, 2020 PR Newswire NEW YORK, Oct. 1, 2020 NEW YORK , Oct. 1, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Allergan plc ("Allergan" or the "Company") (NYSE: AGN) and certain of its officers, on behalf of shareholders who purchased or otherwise...

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc (“Allergan” or “the Company”) (NYSE: AGN ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 9, 2017 and December 19, 2018, inclusive (the ''Class Period''), are encouraged to...

Dr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) Faculty Singh is Scientific Founder of Yuva Biosciences PR Newswire BIRMINGHAM, Ala., June 4, 2020 BIRMINGHAM, Ala. , June 4, 2020 /PRNewswire/ -- Yuva Biosciences , an anti-aging startup based on technology developed by one of the world leaders in mitochondrial sciences, Dr. Keshav K. Singh , is pleased to announce that Dr. Singh joined the Science of Aging SM faculty, a platform owned and run by Allergan Aesthetics Medicine...